PhaseRx Executives

PZRXQDelisted Stock  USD 0.0002  0.00  0.00%   
PhaseRx employs about 10 people. The company is managed by 6 executives with a total tenure of roughly 25 years, averaging almost 4.0 years of service per executive, having 1.67 employees per reported executive. Discussion of PhaseRx's management performance can provide insight into the enterprise performance.
Robert Overell  CEO
President CEO, Principal Accounting Officer, Secretary, Director
Mary Prieve  President
Vice President - Biology
  
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.

PhaseRx Management Team Effectiveness

The company has return on total asset (ROA) of (0.642) % which means that it has lost $0.642 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (2.2817) %, meaning that it generated substantial loss on money invested by shareholders. PhaseRx's management efficiency ratios could be used to measure how well PhaseRx manages its routine affairs as well as how well it operates its assets and liabilities.

PhaseRx Workforce Comparison

PhaseRx is regarded fourth in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 227. PhaseRx holds roughly 10.0 in number of employees claiming about 4% of equities under Health Care industry.

PhaseRx Notable Stakeholders

A PhaseRx stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as PhaseRx often face trade-offs trying to please all of them. PhaseRx's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting PhaseRx's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Robert OverellPresident CEO, Principal Accounting Officer, Secretary, DirectorProfile
Mary PrieveVice President - BiologyProfile
Paul JohnsonCoFounder DirectorProfile
Prof HoffmanCoFounderProfile
Spencer LemonsHead DevelProfile
Patrick StaytonCoFounderProfile

About PhaseRx Management Performance

The success or failure of an entity such as PhaseRx often depends on how effective the management is. PhaseRx management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of PhaseRx management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the PhaseRx management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
PhaseRx, Inc., a biopharmaceutical company, engages in developing a portfolio of products for the treatment of inherited enzyme deficiencies in the liver using intracellular enzyme replacement therapy. The company was incorporated in 2006 and is headquartered in Seattle, Washington. Phaserx operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 10 people.

PhaseRx Workforce Analysis

Traditionally, organizations such as PhaseRx use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare PhaseRx within its industry.

PhaseRx Manpower Efficiency

Return on PhaseRx Manpower

Revenue Per Employee0.0
Revenue Per Executive0.0
Net Loss Per Employee2M
Net Loss Per Executive3.4M
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.
You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Other Consideration for investing in PhaseRx Pink Sheet

If you are still planning to invest in PhaseRx check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the PhaseRx's history and understand the potential risks before investing.
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Stocks Directory
Find actively traded stocks across global markets
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
CEOs Directory
Screen CEOs from public companies around the world